# Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial

> Research article (American Journal of Psychiatry, 2021) · cited 80× · AI/ML

**Wikidata**: [openalex:W3133877026](https://www.wikidata.org/wiki/openalex:W3133877026)  
**Source**: https://4ort.xyz/entity/impact-of-the-kcnq2-3-channel-opener-ezogabine-on-reward-circuit-activity-and-clinical-symptoms-in-depression-results-fr